1. Home
  2. CVAC vs NBN Comparison

CVAC vs NBN Comparison

Compare CVAC & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • NBN
  • Stock Information
  • Founded
  • CVAC 2000
  • NBN 1872
  • Country
  • CVAC Germany
  • NBN United States
  • Employees
  • CVAC N/A
  • NBN N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • NBN Major Banks
  • Sector
  • CVAC Health Care
  • NBN Finance
  • Exchange
  • CVAC Nasdaq
  • NBN Nasdaq
  • Market Cap
  • CVAC 812.1M
  • NBN 752.8M
  • IPO Year
  • CVAC 2020
  • NBN N/A
  • Fundamental
  • Price
  • CVAC $4.10
  • NBN $100.90
  • Analyst Decision
  • CVAC Hold
  • NBN Buy
  • Analyst Count
  • CVAC 3
  • NBN 2
  • Target Price
  • CVAC $10.00
  • NBN $91.00
  • AVG Volume (30 Days)
  • CVAC 1.2M
  • NBN 52.6K
  • Earning Date
  • CVAC 11-12-2024
  • NBN 01-28-2025
  • Dividend Yield
  • CVAC N/A
  • NBN 0.04%
  • EPS Growth
  • CVAC N/A
  • NBN 12.22
  • EPS
  • CVAC N/A
  • NBN 7.69
  • Revenue
  • CVAC $70,565,734.00
  • NBN $157,668,000.00
  • Revenue This Year
  • CVAC $742.57
  • NBN N/A
  • Revenue Next Year
  • CVAC N/A
  • NBN $10.37
  • P/E Ratio
  • CVAC N/A
  • NBN $13.12
  • Revenue Growth
  • CVAC 75.11
  • NBN 16.87
  • 52 Week Low
  • CVAC $2.22
  • NBN $49.07
  • 52 Week High
  • CVAC $5.28
  • NBN $105.44
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 62.06
  • NBN 66.11
  • Support Level
  • CVAC $3.89
  • NBN $89.53
  • Resistance Level
  • CVAC $4.32
  • NBN $95.31
  • Average True Range (ATR)
  • CVAC 0.33
  • NBN 2.39
  • MACD
  • CVAC 0.03
  • NBN 1.09
  • Stochastic Oscillator
  • CVAC 54.27
  • NBN 91.18

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.

Share on Social Networks: